Weiliang Feng

38 Guangji Road
Hangzhou, 310022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Exploring the Role of HNRNPA3 in Breast Cancer Progression, Immune Microenvironment, and Therapeutic Sensitivity: A Multiomics and Functional Prediction Study.

Exploring the Role of HNRNPA3 in Breast Cancer Progression, Immune Microenvironment, and Therapeutic Sensitivity: A Multiomics and Functional Prediction Study.

Journal: Human mutation

Published: January 05, 2026

Preoperative Systemic Therapy Versus Upfront Surgery in HER2-Positive Breast Cancer in the Real World.

Preoperative Systemic Therapy Versus Upfront Surgery in HER2-Positive Breast Cancer in the Real World.

Journal: Frontiers in oncology

Published: May 04, 2021

Expression of Concern: shRNA-mediated silencing of ZFX attenuated the proliferation of breast cancer cells.

Expression of Concern: shRNA-mediated silencing of ZFX attenuated the proliferation of breast cancer cells.

Journal: Cancer chemotherapy and pharmacology

Published: April 12, 2020

A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study.

A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study.

Journal: Diagnostic pathology

Published: January 17, 2019

Knockdown of ribosomal protein S15A inhibits proliferation of breast cancer cells through induction of apoptosis in vitro.

Knockdown of ribosomal protein S15A inhibits proliferation of breast cancer cells through induction of apoptosis in vitro.

Journal: Cytotechnology

Published: December 30, 2017

The Dysregulated Expression of KCNQ1OT1 and Its Interaction with Downstream Factors miR-145/CCNE2 in Breast Cancer Cells.

The Dysregulated Expression of KCNQ1OT1 and Its Interaction with Downstream Factors miR-145/CCNE2 in Breast Cancer Cells.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: November 24, 2017

Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57KIP2 and involving in p-p38 MAPK and NF-κB pathways.

Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57KIP2 and involving in p-p38 MAPK and NF-κB pathways.

Journal: Journal of cellular biochemistry

Published: November 12, 2017

ICT1 knockdown inhibits breast cancer cell growth via induction of cell cycle arrest and apoptosis.

ICT1 knockdown inhibits breast cancer cell growth via induction of cell cycle arrest and apoptosis.

Journal: International journal of molecular medicine

Published: October 11, 2016

PAX6 overexpression is associated with the poor prognosis of invasive ductal breast cancer.

PAX6 overexpression is associated with the poor prognosis of invasive ductal breast cancer.

Journal: Oncology letters

Published: October 14, 2014

Down-regulation of asparagine synthetase induces cell cycle arrest and inhibits cell proliferation of breast cancer.

Down-regulation of asparagine synthetase induces cell cycle arrest and inhibits cell proliferation of breast cancer.

Journal: Chemical biology & drug design

Published: December 29, 2013

shRNA-mediated silencing of ZFX attenuated the proliferation of breast cancer cells.

shRNA-mediated silencing of ZFX attenuated the proliferation of breast cancer cells.

Journal: Cancer chemotherapy and pharmacology

Published: October 20, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026